Submitted by Anonymous (not verified) on 21 August 2025 - 22:25
Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 20, Status: Authorised